US Markets Open: Dow Dips 0.1% as Biotech Stocks See Volatility
As of September 29, US markets opened with the Dow Jones Industrial Average down 0.1%, the S&P 500 up 0.13%, and the Nasdaq up 0.3%. UniQure (QURE) shares fell 39% after its gene therapy trial data failed to meet statistical significance, while Summit Therapeutics (SMMT) rose 19.2% following a $2 billion investment deal with AstraZeneca.
Summaries are written by AI from the original article. Not investment advice.